Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106451

Metabolism of arterial plasma estrogens by the splanchnic organs of the dog in vivo

Delwood C. Collins, Hugh D. Robinson, Carolyn M. Howard, and John R. K. Preedy

Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia 30322

Find articles by Collins, D. in: PubMed | Google Scholar

Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia 30322

Find articles by Robinson, H. in: PubMed | Google Scholar

Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia 30322

Find articles by Howard, C. in: PubMed | Google Scholar

Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia 30322

Find articles by Preedy, J. in: PubMed | Google Scholar

Published December 1, 1970 - More info

Published in Volume 49, Issue 12 on December 1, 1970
J Clin Invest. 1970;49(12):2324–2335. https://doi.org/10.1172/JCI106451.
© 1970 The American Society for Clinical Investigation
Published December 1, 1970 - Version history
View PDF
Abstract

In order to study the splanchnic metabolism of blood-borne estrogens, a constant infusion of estrone-6,7-3H was made in a series of dogs, and arteriovenous (A-V) differences at equilibrium were determined for estrone-6,7-3H and for its products estradiol-17β, estrone sulfate, estrone glucosiduronate, and estradiol-17β glucosiduronate across the splanchnic bed (artery-hepatic vein), the small intestine (artery-superior mesenteric vein), and the spleen (artery-splenic vein). Per cent extractions (100 - [V/A] 100) were calculated. The plasma metabolic clearance rate (MCR) for estrone was measured. Principal findings were as follows: mean MCR was 731 liters/day per m2, SEM 50. By comparison with estimated hepatic plasma flow and using the observed splanchnic extraction of estrone, 45-71% of estrone metabolism was calculated to be extrasplanchnic. The significant mean per cent extractions were as follows (SEM in parentheses): splanchnic bedestrone 85.9 (1.92), estradiol-17β 88.11 (3.36), estrone sulfate 27.9 (5.22), estrone glucosiduronate -48.5 (9.33), estradiol-17β glucosiduronate -33.3 (80.3); small intestine—estrone 45.3 (2.60), estradiol-17β 46.1 (12.9), estrone glucosiduronate - 30.8 (7.9); spleen—estrone 35 (3.8), estrone glucosiduronate 12 (3.7). These results lead to the following conclusions. Both estrone and estradiol-17β are nearly completely extracted in one passage through the splanchnic bed. There is net uptake of estrone sulfate and net production of estrone glucosiduronate and of estradiol-17β glucosiduronate by the splanchnic bed. There is net uptake of estrone and of estradiol-17β by the intestine, associated with substantial net production of estrone glucosiduronate. There is net uptake of estrone by the spleen and a small but significant net uptake of estrone glucosiduronate.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2324
page 2324
icon of scanned page 2325
page 2325
icon of scanned page 2326
page 2326
icon of scanned page 2327
page 2327
icon of scanned page 2328
page 2328
icon of scanned page 2329
page 2329
icon of scanned page 2330
page 2330
icon of scanned page 2331
page 2331
icon of scanned page 2332
page 2332
icon of scanned page 2333
page 2333
icon of scanned page 2334
page 2334
icon of scanned page 2335
page 2335
Version history
  • Version 1 (December 1, 1970): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts